
1. malar j. 2020 may 13;19(1):181. doi: 10.1186/s12936-020-03249-x.

development copy number assays detection surveillance piperaquine
resistance associated plasmepsin 2/3 copy number variation plasmodium
falciparum.

ansbro mr(1)(2), jacob cg(3), amato r(4), kekre m(4), amaratunga c(5), sreng
s(6), suon s(6), miotto o(4)(7)(8), fairhurst rm(5), wellems te(5), kwiatkowski
dp(4)(8).

author information: 
(1)wellcome sanger institute, hinxton, uk. ma20@sanger.ac.uk.
(2)laboratory malaria vector research, national institute allergy and
infectious diseases, national institutes health, rockville, md, usa.
ma20@sanger.ac.uk.
(3)wellcome sanger institute, hinxton, uk. cj9@sanger.ac.uk.
(4)wellcome sanger institute, hinxton, uk.
(5)laboratory malaria vector research, national institute allergy and
infectious diseases, national institutes health, rockville, md, usa.
(6)national center parasitology, entomology, malaria control, phnom penh,
cambodia.
(7)mahidol-oxford tropical medicine research unit, mahidol university, bangkok,
thailand.
(8)centre genomics global health, wellcome centre human genetics,
oxford, uk.

background: long regarded epicenter drug-resistant malaria, southeast
asia continues provide new challenges control plasmodium falciparum 
malaria. recently, resistance artemisinin combination therapy partner drug
piperaquine observed multiple locations across southeast asia.
genetic studies identified single nucleotide polymorphisms well copy
number variations plasmepsin 2 plasmepsin 3 genes, encode
haemoglobin-degrading proteases associate clinical vitro
piperaquine resistance.
results: accurately quickly determine presence copy number
variations plasmepsin 2/3 genes field isolates, study developed 
quantitative pcr assay using taqman probes. copy number estimates validated 
using separate sybr green-based quantitative pcr assay well novel
pcr-based breakpoint assay detect hybrid gene product. field samples 
2012 2015 across three sites cambodia tested using dna extracted 
dried blood spots whole blood monitor extent plasmepsin 2/3 gene
amplifications, well amplifications multidrug resistance transporter
1 gene (pfmdr1), marker mefloquine resistance. study found high
concordance across methods copy number detection. samples derived from
dried blood spots, success rate greater 80% found assay, 
more recent samples performing better. evidence extensive plasmepsin 2/3 copy 
number amplifications observed pursat (94%, 2015) (western cambodia) and
preah vihear (87%, 2014) (northern cambodia), lower levels ratanakiri
(16%, 2014) (eastern cambodia). shift observed two copies of
plasmepsin 2 pursat 2013 three copies 2014-2015 (25% 64%). pfmdr1 
amplifications absent samples preah vihear ratanakiri in
2014 absent pursat 2015.
conclusions: multiplex taqman assay robust tool monitoring both
plasmepsin 2/3 pfmdr1 copy number variations field isolates, the
sybr-green breakpoint assays useful monitoring plasmepsin 2/3
amplifications. study shows increasing levels plasmepsin 2 copy numbers
across cambodia 2012 2015 complete reversion multicopy pfmdr1
parasites single copy parasites study locations.

doi: 10.1186/s12936-020-03249-x 
pmcid: pmc7218657
pmid: 32404110 

